Back to products
Growth
Ipamorelin
Selective GHS receptor agonist
$85
AUD · 5mg vial
99.4% purity
COA included
Lyophilised
In stock
A selective ghrelin receptor agonist studied for growth hormone release with minimal cortisol impact.
Research use only. Not for human consumption, diagnosis, or therapeutic use. For in-vitro and laboratory research purposes only.
- Selective GH release
- Minimal cortisol elevation
- Clean side-effect profile
- Studied for sleep architecture effects
Ipamorelin is a pentapeptide that acts as a selective agonist of the ghrelin receptor (GHS-R1a), stimulating growth hormone release without significantly elevating cortisol, prolactin, or ACTH.
Often studied alongside CJC-1295 for complementary release profiles.
